


Ask a doctor about a prescription for DOXIDINA 25 mg FILM-COATED TABLETS
Leaflet: information for the user
Doxidine 25 mg film-coated tablets
Doxylamine hydrogen succinate
Read this leaflet carefully before starting to take this medicine, as it contains important information for you.
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the leaflet
5 Conservation of Doxidine.
Doxidine is a medicine that contains the active ingredient doxylamine hydrogen succinate.
Doxidine is indicated for the symptomatic treatment of occasional insomnia in adults over 18 years of age.
Patient with persistent sleep problems should consult their doctor.
You should consult a doctor if it worsens or does not improve after 7 days.
Consult your doctor or pharmacist before starting to take Doxidine.
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication. In particular, inform your doctor if you are taking:
Doxylamine may interfere with skin allergy tests that use allergens. It is recommended to discontinue treatment with Doxidine at least three days before starting such tests.
Alcoholic beverages should not be consumed during treatment with Doxidine.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
Because doxylamine crosses the placenta, as a precaution, it is preferable to avoid the use of Doxylamine during pregnancy, unless the potential benefit of treating the mother outweighs the possible risks to the developing fetus.
Because of the excretion of doxylamine succinate in breast milk and the risk of using antihistamines in young children, Doxidine should not be used during breastfeeding.
No data are available on the possible effects of Doxidine on fertility.
The influence of Doxidine on the ability to drive and use machines is significant. Do not drive or use hazardous machinery while taking this medication, at least during the first days of treatment, until you know how it affects you.
Doxidine contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
The recommended dose is 1 tablet (25 mg) per day.
If daytime drowsiness occurs, it is recommended to reduce the dose from 25 to 12.5 mg per day or take it earlier to ensure that at least 8 hours pass until waking time.
Do not take more than 1 tablet (25 mg) per day.
People over 65 years old are more likely to suffer from other pathologies that may recommend a dose reduction (see section 4.4). It is recommended to start with a dose of 12.5 mg (1 tablet of 12.5 mg), administered 30 minutes before bedtime. The dose can be increased to 25 mg (1 tablet) if the 12.5 mg dose is ineffective in eliminating insomnia. In case of unwanted side effects, it is recommended to reduce the dose to 12.5 mg per day.
These patients should take a different dose, adjusted to the degree of their disease, which will be determined by the doctor.
Doxidine is not recommended for use in children under 18 years old, so this medication should not be used in this population.
Oral route.
The tablets should be taken 30 minutes before bedtime with a sufficient amount of liquid (preferably water).
Doxidine can be taken before or after meals.
The score line is only for breaking and facilitating swallowing.
The duration of treatment should be as short as possible. In general, the duration of treatment can range from a few days to a week.
It should not be administered for a period exceeding 7 days without consulting a doctor.
The symptoms of an overdose include: drowsiness, depression or stimulation of the central nervous system, anticholinergic effects (dilated pupils, fever, dry mouth, decreased intestinal tone), flushing, increased or altered heart rate, increased blood pressure, nausea, vomiting, agitation, alteration of gait, dizziness, irritability, sedation, confusion, and hallucinations. Delirium, psychosis, decreased blood pressure, seizures, decreased respiration, loss of consciousness, coma, and death may occur. A serious complication can be rhabdomyolysis (muscle damage), followed by kidney failure.
There is no specific antidote for antihistamine overdose, so treatment is symptomatic and supportive. Your doctor will assess the need to induce vomiting, perform stomach lavage, or prescribe medications to increase blood pressure if necessary.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Do not take a double dose to make up for forgotten doses. Take your dose at the usual time the next day.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, Doxidine can cause side effects, although not everyone will experience them.
The side effects of doxylamine are generally mild and transient, being more frequent in the first days of treatment.
Common side effects (may affect up to 1 in 10 people):drowsiness and effects such as dry mouth, constipation, blurred vision, urinary retention, increased bronchial secretion, vertigo, dizziness, headache, pain in the upper abdominal area, fatigue, insomnia, and nervousness.
Uncommon side effects (may affect up to 1 in 100 people):asthenia (fatigue), peripheral edema (inflammation of arms and legs), nausea, vomiting, diarrhea, skin rash, tinnitus (ringing in the ears), orthostatic hypotension (decreased blood pressure due to postural changes), diplopia (double vision), dyspepsia (stomach disorders), feeling of relaxation, nightmares, and dyspnea (breathing difficulties).
Rare side effects (may affect up to 1 in 1,000 people):agitation (especially in children and people over 65 years old), tremors, seizures, or blood disorders such as hemolytic anemia, thrombocytopenia, leukopenia, or agranulocytosis (decrease in certain blood cells).
Side effects of unknown frequency (cannot be estimated from available data): general malaise.
If you experience any type of side effect, consult your doctor or pharmacist, even if it is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines (www.notificaram.es). By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the box or blister after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Keep the medication in its original packaging.
Each tablet contains 25 mg of doxylamine hydrogen succinate.
The other components are:
Core excipients:
Mannitol
Microcrystalline cellulose
Sodium starch glycolate (type A)
Anhydrous colloidal silica
Magnesium stearate
Coating excipients:
Hypromellose
Titanium dioxide (E-171)
Macrogol 400
Indigotine (E-132)
Doxidine is presented in oval, biconvex, film-coated tablets, scored and blue in color, in aluminum blisters containing 7, 10, 14, or 20 tablets.
Only some package sizes may be marketed.
Teva B.V.
Swensweg, 5
2031GA Haarlem, Netherlands
Manufacturer
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna, 66-68-70. Pol. Industrial Urtinsa II
28923 Alcorcón, Madrid
Spain
Local representative
Teva Pharma S.L.U.
C/Anabel Segura 11,
Edificio Albatros B 1ªplanta
28108 Alcobendas, Madrid
Spain
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DOXIDINA 25 mg FILM-COATED TABLETS – subject to medical assessment and local rules.